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The administration of thyroxine to neonatal rats stimulates RNA synthesis by neuronal nuclei isolated 
from the developing rat brain cortex. Glial nuclei are relatively resistant to thyroxine treatment. The 
activity of neuronal RNA polymerase II is particularly stimulated by the hormone. Thyroxine also affects 
neuronal chromatin structure as shown by changes in the relative proportion of different subnuclear 
fractions obtained by gentle micrococcal nuclease digestion of nuclei from hormone-treated rats. 
Thyroid hormone Development Rat brain cortex Brain cell nucleus RNA pofymerase 
~icro~occal nuclease 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The mechanism by which thyroid hormones pro- 
mote growth and maturation of the mammalian 
brain is not fully understood [ 11. Available data 
suggest hat thyroid hormones stimulate RNA and 
protein syntheses in target tissue by interacting 
with specific chromatin-bound receptors [2]. Thus 
it has been shown that triiodothyronine enhances 
the synthesis of poly(A)-containing RNA in liver 
[3] and increases the level of growth hormone 
mRNA in rat pituitary cells in culture [4,5]. 
Previous studies have also shown that 
triiodothyronine administration increases the ac- 
tivities of RNA polymerases in rat liver [6] and 
brain tissue 1’71. 
t3H]UTP and [3H]poly(U) were purchased from 
the Radiochemical Centre (Amersham) and cy- 
amanitin was obtained from Boehringer- 
Mannheim. Micrococcal n&lease was obtained 
from Worthington 3iochemic~s. The source of 
the rest of the materials has been described in [B]. 
Recently it was shown that neuronal RNA and 
protein syntheses are influenced by the thyroid 
status of neonatal rats [B]. This study was under- 
taken to investigate the effect of neonatal thyrox- 
ine treatment on RNA metabolism in isolated 
nuclear fractions enriched in neuronal and glial cell 
nuclei. It was also examined whether thyroxine ad- 
ministration affects brain cell chromatin structure 
as studied by gentle micrococcal nuclease digestion 
of isolated nuclei [9, lo]. 
Neonatal rats of the Wistar strain received saline 
or sodium L-thyroxine (10 fig/animal) every third 
day as in [ 111. The animals were killed 24 h follow- 
ing the last hormone injection and the brains were 
rapidly removed. Cortical tissues were homogen- 
ized in 20-25 vols ice-cold 1.6 M sucrose in TM 
buffer (3 mM MgClz-10 mM Tris-HCI, pH 7.5, 
at 20°C) and the homogenate fraction was centri- 
fuged over 2.0 M sucrose in TM buffer to prepare 
nuclei. The crude nuclear pellet obtained was 
subsequently resuspended in 2.38 M sucrose in TM 
buffer and neuronal and ghal cell enriched nuclei 
were prepared by discontinuous sucrose density 
gradient centrifugation as in [12-141. The purity 
of nuclear fractions was studied by phase-contrast 
microscopy and different nuclei were identified by 
the criteria described in [14,15]. Nuclei were 
resuspended in 25% (v/v) glycerol and 1 mM 
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MgClz-10 mM Tris-HCl (pH 7.9) and were used tion during the reaction. Blank values obtained 
immediately for the study of RNA synthesis in with samples kept on ice for the same period of 
vitro. time were subtracted from all data points. 
The standard nuclear reaction mixture was 
essentially as in [ 161. It contained in a final volume 
of 0.2 ml, nuclei (40-6Opg DNA), 40 mM 
Tris-HCl (pH 7.9), 2 mM MgCL, 1.5 mM MnC12, 
0.5 mM dithiothreitol, 0.3 mM each of ATP, 
CTP, GTP, 0.05 mM unlabelled UTP, 1 &i 
[3H]UTP (spec. act. 45 Ci/mmol) and either 25 or 
250 mM (NH&S04 (low- and high-salt condi- 
tions, respectively). Where indicated, a-amanitin 
(1 pg/ml) was added to the reaction mixture to in- 
hibit specifically the activity of RNA polymerase II 
[17]. Following incubation at 25°C the reaction 
was terminated by the addition of 0.5 ml ice-cold 
10% (w/v) trichloroacetic acid and 0.5 mg bovine 
serum albumin. The samples were washed with 5% 
trichloroacetic acid and the acid-insoluble radioac- 
tivity was determined as in [8]. 
Micrococcal nuclease treatment of brain nuclei, 
washed with 0.1% (v/v) Triton X-100, was per- 
formed essentially as in [9]. Digestion was carried 
out for 2 min at 25°C with 0.5 units nuclease per 
A260 unit nuclei and the reaction was stopped by 
the addition of 2 mM EGTA. Subnuclear fractions 
were subsequently prepared as in [9] and the 
recovery of DNA in different fractions was deter- 
mined as in [8]. 
3. RESULTS AND DISCUSSION 
The poly(U)-degrading activity of brain nuclei 
was measured under identical conditions to those 
described above except that the nucleoside 
triphosphates were omitted from the reaction and 
50 nCi [3H]poly(U) was used as the substrate. 
Following incubation for 60 min at 25°C the reac- 
tion was terminated as described above. The activi- 
ty was expressed as the amount of radioactivity 
liberated from poly(U) into the supernatant frac- 
The results presented in table 1 show that 
thyroxine treatment of neonatal rats significantly 
(36%) stimulates the RNA synthetic activity of 
neuronal nuclei in both age groups studied. The ac- 
tivity of glial nuclei is relatively more resistant o 
the hormone administration (table 1). These results 
are in keeping with that of a recent study showing 
that thyroid hormone receptors in developing 
chick brain reside predominantly in the neuronal 
nuclei [ 181. 
Table 1 also shows that the stimulation of 
neuronal transcription by thyroxine is diminished 
in the presence of a low concentration of LY- 
amanitin to inhibit the activity of RNA polymerase 
Table 1 
The effect of thyroxine treatment on the synthesis of RNA by isolated brain cell nuclei 
Age 
(days) 
cu-Amanitin [3H]UMP incorporated (X 10e3) (cpm/mg DNA) 
Neuronal nuclei Glial nuclei 
Control + thyroxine Control + thyroxine 
‘9 (9) - 13.2 + 0.4 17.9 f l.OOb 14.6 rt 1.1 15 f 0.9 
+ 7.0 + 0.6 7.8 f 0.7a 12.2 * 0.7 12.9 f 0.8 
18-21 - 9.9 f 1.2 13.9 f l.lb 6.6 f 0.6 6.8 f 1.0 
(8) + 4.8 f 0.5 5.9 f 0.6a 3.3 f 0.2 3.4 f 0.5 
=p c 0.05 
b p c 0.01 as determined by Student’s t-test 
Nuclear fractions enriched in neuronal and glial cell nuclei were prepared from the developing brain cortex of control 
and thyroxine-treated rats (see section 2). Isolated nuclei were incubated in vitro for 10 min at 25°C under low-salt 
conditions in the absence and presence of cu-amanitin (1 pg/ml) as described in section 2. The results are given as 
means + SD of the number of different preparations of nuclei (in parentheses) 
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II. The addition of a higher concentration of CX- 
amanitin (100 pg/ml) to the assays, to inhibit RNA 
~olymerase III activity f171, resuked in a 10% fur- 
ther decrease in the activity of different brain 
nuclei (not shown), Thus the results in table f in- 
dicate that thyroxine treatment significantly 
~nh~c~s the activity of neuro~a~ RNA ~o~~~rase 
II and has a minor effect on that of RNA 
polymerase I. This finding agrees with the results 
of a previous tudy showing no s~bsta~t~~ effect 
of repeated thyroxiine injections on the activity of 
RNA ~oIymerase I in isufated nuclei from 
hypothyroid rat cerebrum 171. However, previous 
studies have shown that tr~~~othyron~~e treat- 
ment markedly enhances the activity uf RNA 
polymerase I. in rat Iiver nuclei f6J and in hindlimb 
nuclei of Rana c~~~~~~~~~~ tadpoles [191 S
The discrepancies in the results obtained could 
be due to the different rates of ribosomal RNA 
synthesis n rat liver and brain tissue [ZO]. It is abo 
possible that thyroxine activates the two forms of 
neurona RNA ~~l~erases at differed times 
following the hormone treatment as has been 
shown for the corresponding enzymes in rat liver 
[6,21]. Here, animals were decapitated 24 h after 
the last horrno~~ ~~~~io~. 
The time course of [~~J~T~ j~~orpo~ati~n into
nascent RNA by isolated brain nuclei s shown ia 
fig.1. RNA synthesis by different brain nuclei in 
vitro is finear for about IO and 30 min under Iow- 
and high-salt conditions, respectively. More than 
80% of the activity measured in the presence of 
Fig. 1+ Time course of f3HfUTP j~co~~rat~on i to RNA 
by isolated brain nuclei from I8-day-old rats. Nuclei 
were incubated in vitro for different time intervals at 
25°C under low-salt <a) and high-salt (b) conditions. 
Neuronal nuclei: @---0) control rats; (+---& 
hormone-treated rats. EIiaI nuclei: (k-4) eontrof rats; 
(A--&$ hormone-treated rats. The ordinates are 
different in (a) and (b)” 
high-salt was inhibited by low cou~~~tratious f Q- 
~~~t~~ and thus re~r~s~~t~ tra r~~t~o~ due to 
RNA ~~l~rneras~ II (cf, 1141). Thyroxine increases 
the activity of neuronal nuclei assayed at different 
ionic strength without affecting that of glial nuclei 
(fig. 1). 
To determine whether thyroxine influences the 
degradation of nascent RNA by isolated brain 
nu&i, in~ubat~on was p~rf~rrn~ in the presence 
of radioactive ~0~~~~~~ The results presented in 
table 2 show that neuronal nuclei from ~uthyroid 
and thyroxine-treated rats exhibit the same 
Table 2 
The effect of thyroxine ~~ea~e~t on poly(~~~de~radin~ ctivity in brain m~cIei 
Saurce of Nuclear ~u~~~~~d~grad~ng activity 
nuclei fraction ~~rn/~~ DNA) 
- ATA + ATA 
Cantrol rats Neurone 37.9 s 1.2 6.9 rl: 0.8 
Glia 26.7 f 0.6 4.2 $ 03 
~~~roxin~-heated rats Neurons 39.1 a 1.9 6.2 I 0.7 
Glia 2.5.8 f 1.2 4.6 f 0.8 
Brain nuclei obtained from g-day-old rats were incubated for 60 min at 2SaC 
in the presence of radioactive ~0~~~~) {see section 2). Aurin tricarboxylic acid 
(0.1 mM) was added to the assays to inhibit ribonudease activity. The results 
are means f SD of 5 different experiments, and represent the amount of 
radioactivity liberated from the ~~~~~~y~) substrate during incubation 
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poly(U)-degrading activity. It is also shown that 
the antibiotic aurin tricarboxylic acid, which is a 
potent inhibitor of ribonuclease [22], decreases the 
endogenous nuclease activity of control and hor- 
mone-treated nuclei to the same extent (table 2). 
Pulse-chase experiments employing unlabelled 
UTP also revealed that nascent RNA chains syn- 
thesized by neuronal nuclei from control and 
hormone-treated rats have the same stability in 
vitro (not shown). 
The results of a number of studies indicate that 
the activation of transcription is accompanied by 
changes in chromatin structure [23 1. Micrococcal 
nuclease has been shown to excise preferentially 
genes being actively transcribed by attacking the 
linker region between nucleosomes [24,25]. To in- 
vestigate whether thyroxine induces a change in the 
structure of neuronal chromatin, nuclei from con- 
trol and hormone-treated rats were gently digested 
with micrococcal nuclease. This procedure has 
been shown to resolve the chromatin into two frac- 
tions with different transcriptional capacities 
[9,26]. The results in table 3 show that thyroxine 
treatment increases the relative proportion of the 
subnuclear fraction Pz, which sediments at high 
speed and which has been shown to be enriched in 
active transcribing chromatin [9,26]. Thus DNA in 
this neuronal fraction comprises about 10% of 
total DNA in controls, whereas the corresponding 
figure in thyroxine-treated rats is increased to 14% 
(table 3). It has also been shown that the suscep- 
tibility of rat liver chromatin to digestion with 
micrococcal nuclease is enhanced following 
triiodothyronine treatment of thyroidectomized 
rats [27]. The structural basis for the increased 
nuclease sensitivity of nuclei from hormone- 
treated rats remains unknown. 
Thyroid hormones have been shown to exert 
multiple effects on cellular metabolism in target 
tissue [2]. Our results demonstrate that thyroxine 
preferentially stimulates RNA synthesis by isolated 
neuronal nuclei in the developing rat brain cortex. 
The relative resistance of RNA metabolism in glial 
nuclei to thyroxine treatment is consonant with the 
preponderance of thyroid hormone receptors in 
neuronal nuclei [ 181. The results of previous 
studies indicate that the outgrowth of neuronal 
processes and the differentiation of the nerve cell 
are markedly retarded in the hypothyroid brains of 
neonatal rats [1,8]. However, the process of 
Table 3 
Distribution of DNA in different subnuclear f actions 
obtained by mild micrococcal nuclease treatment of 
neuronal nuclei from control and hormone-treated rats 
Source of nuclei 
Control rats 
(n = 6) 
Thyroxine-treated 
rats (n = 10) 
= p < 0.01 
Subnuclear DNA recovered 
fraction (To of total) 
PI pellet 88.3 f 0.4 
PZ pellet 9.9 + 0.2 
Supernatant 1.8 + 0.3 
Pr pellet 84.9 * 0.3” 
Pz pellet 14.0 f 0.3” 
Supernatant 1.1 f 0.2 
Neuronal nuclei were digested with micrococcal nuclease 
and the different subnuclear fractions were obtained by 
differential centrifugation as in section 2 
myelination is also impaired in these animals with 
a possible permanent deficit in the total amount of 
myelin deposited [28]. It remains to be elucidated 
whether the derangement of glial cell metabolism 
in hypothyroidism is secondary to alterations in 
neuronal RNA and protein syntheses or whether 
thyroid hormones directly influence myelination as 
has been suggested [29]. 
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